The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises

被引:33
作者
Ortega, Angel [1 ]
Vera, Ivana [1 ]
Diaz, Maria P. [1 ]
Navarro, Carla [1 ]
Rojas, Milagros [1 ]
Torres, Wheeler [1 ]
Parra, Heliana [1 ]
Salazar, Juan [1 ]
De Sanctis, Juan B. [2 ]
Bermudez, Valmore [3 ]
机构
[1] Univ Zulia, Sch Med, Endocrine & Metab Dis Res Ctr, Maracaibo 4004, Venezuela
[2] Palacky Univ Olomouc, Inst Mol & Translat Med, Fac Med & Dent, Olomouc 77900, Czech Republic
[3] Univ Simon Bolivar, Fac Ciencias Salud, Barranquilla 080002, Colombia
关键词
YAP; TAZ; TEAD; Hippo signaling pathway; carcinogenesis; tumor microenvironment; neoplastic stem cells; cell proliferation; drug resistance; chemoresistance; immunotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; HIPPO PATHWAY; BREAST-CANCER; CLINICAL-IMPLICATIONS; MEDIATES RESISTANCE; MEVALONATE PATHWAY; TARGETING YAP; ORGAN SIZE; TAZ; PROMOTES;
D O I
10.3390/ijms23010430
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators, members of the Hippo signaling pathway, which play a critical role in cell growth regulation, embryonic development, regeneration, proliferation, and cancer origin and progression. The mechanism involves the nuclear binding of the un-phosphorylated YAP/TAZ complex to release the transcriptional enhanced associate domain (TEAD) from its repressors. The active ternary complex is responsible for the aforementioned biological effects. Overexpression of YAP/TAZ has been reported in cancer stem cells and tumor resistance. The resistance involves chemotherapy, targeted therapy, and immunotherapy. This review provides an overview of YAP/TAZ pathways' role in carcinogenesis and tumor microenvironment. Potential therapeutic alternatives are also discussed.
引用
收藏
页数:22
相关论文
共 165 条
  • [11] Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
    Calvo, Fernando
    Ege, Nil
    Grande-Garcia, Araceli
    Hooper, Steven
    Jenkins, Robert P.
    Chaudhry, Shahid I.
    Harrington, Kevin
    Williamson, Peter
    Moeendarbary, Emad
    Charras, Guillaume
    Sahai, Erik
    [J]. NATURE CELL BIOLOGY, 2013, 15 (06) : 637 - +
  • [12] Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
    Canu, Valeria
    Donzelli, Sara
    Sacconi, Andrea
    Lo Sardo, Federica
    Pulito, Claudio
    Bossel, Noa
    Di Benedetto, Anna
    Muti, Paola
    Botti, Claudio
    Domany, Eytan
    Bicciato, Silvio
    Strano, Sabrina
    Yarden, Yosef
    Blandino, Giovanni
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (05) : 1493 - 1511
  • [13] A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
    Chang, Cheng
    Goel, Hira Lal
    Gao, Huijie
    Pursell, Bryan
    Shultz, Leonard D.
    Greiner, Dale L.
    Ingerpuu, Sulev
    Patarroyo, Manuel
    Cao, Shiliang
    Lim, Elgene
    Mao, Junhao
    Mckee, Karen Kulju
    Yurchenco, Peter D.
    Mercurio, Arthur M.
    [J]. GENES & DEVELOPMENT, 2015, 29 (01) : 1 - 6
  • [14] Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
    Chen, Guangyuan
    Xie, Jiabin
    Huang, Ping
    Yang, Zhihong
    [J]. ONCOLOGY LETTERS, 2016, 12 (03) : 1821 - 1825
  • [15] WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis
    Chen, Yu-An
    Lu, Chen-Yu
    Cheng, Tian-You
    Pan, Szu-Hua
    Chen, Hsin-Fu
    Chang, Nan-Shan
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [16] Systematic analysis of the Hippo pathway organization and oncogenic alteration in evolution
    Chen, Yuxuan
    Han, Han
    Seo, Gayoung
    Vargas, Rebecca Elizabeth
    Yang, Bing
    Chuc, Kimberly
    Zhao, Huabin
    Wang, Wenqi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01) : 3173
  • [17] Cheng D, 2020, INT J CLIN EXP PATHO, V13, P701
  • [18] Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease
    Cobbaut, Mathias
    Karagil, Simge
    Bruno, Lucrezia
    de la Loza, Maria Del Carmen Diaz
    Mackenzie, Francesca E.
    Stolinski, Michael
    Elbediwy, Ahmed
    [J]. CELLS, 2020, 9 (01)
  • [19] YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling
    Coggins, Grace E.
    Farrel, Alvin
    Rathi, Komal S.
    Hayes, Colin M.
    Scolaro, Laura
    Rokita, Jo Lynne
    Maris, John M.
    [J]. CANCER RESEARCH, 2019, 79 (24) : 6204 - 6214
  • [20] The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
    Cordenonsi, Michelangelo
    Zanconato, Francesca
    Azzolin, Luca
    Forcato, Mattia
    Rosato, Antonio
    Frasson, Chiara
    Inui, Masafumi
    Montagner, Marco
    Parenti, Anna R.
    Poletti, Alessandro
    Daidone, Maria Grazia
    Dupont, Sirio
    Basso, Giuseppe
    Bicciato, Silvio
    Piccolo, Stefano
    [J]. CELL, 2011, 147 (04) : 759 - 772